Who benefits from SMEs’ radical innovations?—empirical evidence from German biotechnology
Crossref DOI link: https://doi.org/10.1007/s11187-021-00464-x
Published Online: 2021-03-15
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shkolnykova, Mariia http://orcid.org/0000-0002-7186-619X
Kudic, Muhamed http://orcid.org/0000-0003-3677-8300
Funding for this research was provided by:
Universität Bremen
Text and Data Mining valid from 2021-03-15
Version of Record valid from 2021-03-15
Article History
Revised: 20 December 2020
First Online: 15 March 2021